Get started
JetEquities

TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Progra

Long
Dynavax Technologies Corporation (NASDAQ:DVAX)  
JetEquities  
NASDAQ:DVAX   Dynavax Technologies Corporation
Beyond Technical Analysis
3
0
beyondta
DVAX: Dynavax Technologies Corporation
2020-08-03 08:00:10
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.